Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trial

Blood (2025) 146 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2025-4699

Published: 2025

Journal Articles

Impact of long-term luspatercept treatment on iron parameters in patients with transfusion-dependent and non-transfusion-dependent β-thalassemia: Results from the phase 3b long-term follow-up study

Ali Taher, Khaled Musallam, Maria Domenica Cappellini, Maria Dimopoulou, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, Manuela Balocco, Patricia Martin-Regueira, Loyse Felber Medlin, George Zhang, Veronika Pozharskaya, John Porter

Blood (2025) 146 (Supplement 1): 4695.

https://doi.org/10.1182/blood-2025-4695

Published: 2025

Journal Articles

Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus

Nicoletta Di Maio, Giovanna Russo, Susanna Barella, MD, Gian Luca Forni, MD, Raffaella Colombatti, MDPhD, Lucia Notarangelo, Giovanna Graziadei, MD, Antonella Sau, MD, Luciana Rigoli, Piero Farruggia, Saveria Campisi, MD, Tommaso Casini, Manuela Balocco, MD, Gianluca Boscarol, Ilaria Capolsini, MD, Paolo Grotto, MD, Fiorina Giona, MD, Ilaria Lazzareschi, MD, Pellegrina Pugliese, MD, Francesca Fioredda, PhD, Silvia Fasoli, Maria Caterina Putti, MD, Maddalena Migliavacca, MD PhD, Corti Paola, MD, Serena Tripodi, MD, Paola Saracco, MD, Simone Ferrero, MD, Assunta Tornesello, MD, Marilena Serra, MD, Saverio Ladogana, MD, Giovanni Palazzi, MD, Federico Verzegnassi, MD, Carlo Baronci, MD, Giuseppe Palumbo, MD, Simone Cesaro, MD, Laura Sainati, MD, Flavia Rivellini, MD, Rosanna Di Concilio, MD, Vania Munaretto, MD, Elena Facchini, MD, Paola Giordano, MD, Maria Grazia Sanna, Silverio Perrotta, MD, Maddalena Casale, MD PhD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-142335

Published: 2020

Journal Articles

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Irene Motta, MD, Valeria Maria Pinto, MD, Filomena Longo, MD, Federico Bonetti, MD, Elisa De Michele, MD, Alberto Piperno, MD, Lorella Pitrolo, MD, Micol Quaresima, MD, Michela Ribersani, MD, Margherita Migone De Amicis, MD, Manuela Balocco, MD, Barbara Gianesin, PhD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Lucia De Franceschi, MD, Antonio Piga, MD, Gian Luca Forni, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141610

Published: 2020

Journal Articles

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Gian Luca Forni, MD, Marina Podestà, Marco Musso, Giovanna Piaggio, Khaled M Musallam, Manuela Balocco, Sarah Pozzi, Francesco Frassoni

Blood (2012) 120 (21): 5178.

https://doi.org/10.1182/blood.V120.21.5178.5178

Published: 2012

Journal Articles

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Gianluca Forni, MD, Manuela Balocco, Laura Terenzani, Paola Carrara

Blood (2008) 112 (11): 4815.

https://doi.org/10.1182/blood.V112.11.4815.4815

Published: 2008

Journal Articles

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, MD, PhD, Alessandro Pulsoni, MD, Manuela Balocco, MD, Monica Tani, MD, Stefano Fanti, MD, Alessio Perrotti, MD, Paolo Castellucci, MD, Francesco Zaja, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Maria Teresa Voso, MD, Pierpaolo Fattori, MD, Luciano Guardigni, MD, Patrizia Gentilini, MD, Maria Giuseppina Cabras, MD, Amalia De Renzo, MD, Luigi Rigacci, MD

Blood (2006) 108 (11): 2479.

https://doi.org/10.1182/blood.V108.11.2479.2479

Published: 2006

Journal Articles

Evidence for Killing of Mesenchymal Stem Cells (MSC) by Autologous Natural Killer Lymphocytes.

Alessandro Poggi, MD, PhD, Anna-Maria Massaro, PhD, Simone Negrini, MD, Ivana Pierri, MD, Manuela Balocco, MD, Gianluca Michelis, MD, Sara Aquino, MD, Alessandra Albarello, MD, Marco Gobbi, MD, Maria Raffaella Zocchi, MD

Blood (2004) 104 (11): 1290.

https://doi.org/10.1182/blood.V104.11.1290.1290

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trial

Impact of long-term luspatercept treatment on iron parameters in patients with transfusion-dependent and non-transfusion-dependent β-thalassemia: Results from the phase 3b long-term follow-up study

Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.

Evidence for Killing of Mesenchymal Stem Cells (MSC) by Autologous Natural Killer Lymphocytes.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only